Shares of Vital Farms, Inc. (NASDAQ:VITL - Get Free Report) have earned an average recommendation of "Buy" from the eleven ratings firms that are covering the firm, Marketbeat reports. Eleven equities research analysts have rated the stock with a buy rating. The average 12-month price target among brokers that have issued a report on the stock in the last year is $49.80.
A number of equities analysts have recently issued reports on VITL shares. DA Davidson raised their price target on Vital Farms from $51.00 to $52.00 and gave the stock a "buy" rating in a research note on Monday, August 11th. Telsey Advisory Group lifted their target price on Vital Farms from $46.00 to $50.00 and gave the company an "outperform" rating in a research report on Friday, August 8th. BMO Capital Markets raised their price target on Vital Farms from $50.00 to $60.00 and gave the company an "outperform" rating in a report on Tuesday, September 2nd. Lake Street Capital set a $60.00 price target on Vital Farms and gave the company a "buy" rating in a report on Friday, August 8th. Finally, Stifel Nicolaus raised their price target on Vital Farms from $44.00 to $48.00 and gave the company a "buy" rating in a report on Friday, August 8th.
View Our Latest Analysis on VITL
Insiders Place Their Bets
In other news, SVP Stephanie Coon sold 10,005 shares of the company's stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $46.15, for a total transaction of $461,730.75. Following the transaction, the senior vice president directly owned 45,779 shares of the company's stock, valued at approximately $2,112,700.85. This represents a 17.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Matthew Ohayer sold 145,000 shares of the company's stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $51.98, for a total value of $7,537,100.00. Following the completion of the transaction, the insider directly owned 6,582,070 shares in the company, valued at approximately $342,135,998.60. The trade was a 2.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 439,401 shares of company stock worth $21,848,580 over the last three months. 21.30% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of VITL. Caitong International Asset Management Co. Ltd raised its holdings in Vital Farms by 20,650.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,660 shares of the company's stock valued at $51,000 after acquiring an additional 1,652 shares during the last quarter. US Bancorp DE boosted its position in Vital Farms by 36.2% in the 1st quarter. US Bancorp DE now owns 1,929 shares of the company's stock valued at $59,000 after buying an additional 513 shares during the period. CWM LLC boosted its position in Vital Farms by 43.2% in the 1st quarter. CWM LLC now owns 2,154 shares of the company's stock valued at $66,000 after buying an additional 650 shares during the period. Union Bancaire Privee UBP SA purchased a new position in Vital Farms in the 1st quarter valued at approximately $112,000. Finally, Assetmark Inc. boosted its position in Vital Farms by 18.9% in the 2nd quarter. Assetmark Inc. now owns 3,153 shares of the company's stock valued at $121,000 after buying an additional 501 shares during the period. 98.59% of the stock is owned by hedge funds and other institutional investors.
Vital Farms Trading Up 0.2%
NASDAQ VITL traded up $0.08 on Tuesday, hitting $48.56. The company's stock had a trading volume of 707,068 shares, compared to its average volume of 1,099,652. Vital Farms has a 52-week low of $27.91 and a 52-week high of $53.13. The firm has a market cap of $2.17 billion, a P/E ratio of 43.36 and a beta of 0.94. The company's 50-day simple moving average is $43.73 and its 200 day simple moving average is $36.93. The company has a current ratio of 2.48, a quick ratio of 2.10 and a debt-to-equity ratio of 0.02.
Vital Farms (NASDAQ:VITL - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating analysts' consensus estimates of $0.27 by $0.09. Vital Farms had a return on equity of 18.40% and a net margin of 7.84%.The company had revenue of $184.77 million during the quarter, compared to analyst estimates of $170.28 million. During the same quarter last year, the company earned $0.36 EPS. The firm's revenue for the quarter was up 25.4% on a year-over-year basis. Vital Farms has set its FY 2025 guidance at EPS. Research analysts predict that Vital Farms will post 1.11 EPS for the current fiscal year.
Vital Farms Company Profile
(
Get Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Further Reading

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.